Cargando…
Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response
SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a deadly thoracic malignancy with limited treatment options. Chemotherapy remains the most widely used first-line treatment for unresectable MPM but is hampered by drug resistance issues. Small molecule inhibitors and microRNA mimics have shown...
Autores principales: | Johnson, Ben, Zhuang, Ling, Rath, Emma M., Yuen, Man Lee, Cheng, Ngan Ching, Shi, Huaikai, Kao, Steven, Reid, Glen, Cheng, Yuen Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564288/ https://www.ncbi.nlm.nih.gov/pubmed/36230710 http://dx.doi.org/10.3390/cancers14194784 |
Ejemplares similares
-
The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM)
por: Yuen, Man Lee, et al.
Publicado: (2021) -
MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients
por: Lin, Ruby C.Y., et al.
Publicado: (2016) -
Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways
por: Williams, Marissa, et al.
Publicado: (2019) -
Leptospermum extract (QV0) suppresses pleural mesothelioma tumor growth in vitro and in vivo by mitochondrial dysfunction associated apoptosis
por: Shi, Huaikai, et al.
Publicado: (2023) -
SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma
por: Cheng, Yuen Yee, et al.
Publicado: (2017)